NASDAQ:GHSI Guardion Health Sciences (GHSI) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free GHSI Stock Alerts $8.02 +0.03 (+0.38%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$7.95▼$8.2150-Day Range$7.82▼$9.1052-Week Range$5.01▼$10.75Volume2,761 shsAverage Volume13,531 shsMarket Capitalization$10.27 millionP/E Ratio72.92Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Guardion Health Sciences alerts: Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About Guardion Health Sciences Stock (NASDAQ:GHSI)Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.Read More GHSI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GHSI Stock News HeadlinesApril 17, 2024 | morningstar.comGuardion Health Sciences Inc GHSIApril 15, 2024 | finance.yahoo.comGuardion Health Sciences, Inc. (GHSI)April 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.April 14, 2024 | americanbankingnews.comGuardion Health Sciences (GHSI) Set to Announce Quarterly Earnings on MondayApril 9, 2024 | msn.comMolecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals among healthcare moversApril 4, 2024 | msn.comAccess Bank Ghana makes historic GHS One billion plus profit before taxApril 1, 2024 | finance.yahoo.comWhy Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth WatchingMarch 29, 2024 | markets.businessinsider.comGuardion Health Swings To Annual Net Profit, Revenue ImprovesApril 23, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.March 29, 2024 | globenewswire.comGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023March 28, 2024 | finance.yahoo.comGHS Label Market Set to Achieve Steady Growth with a 3.4% CAGR through 2034 | Future Market Insights Inc.February 24, 2024 | msn.comGuardion Health Sciences (GHSI) Price Target Increased by 233.33% to 40.80February 1, 2024 | realmoney.thestreet.comMaxim gets more bearish on Guardion Health Sciences, downgrades sharesFebruary 1, 2024 | msn.comWhy Guardion Health Sciences Stock Is Up TodayFebruary 1, 2024 | msn.comGuardion Health Sciences Sells Activ to Doctor’s BestJanuary 31, 2024 | marketwatch.comGuardion Health Shares Soar Premarket on Deal to Sell ViactivJanuary 31, 2024 | markets.businessinsider.comWhy Is Guardion Health (GHSI) Stock Up 66% Today?January 30, 2024 | finance.yahoo.comGuardion Health Sciences Announces Entry into Definitive Agreement to Sell its Well-Known Viactiv® Brand and Business to Doctor’s Best Inc.November 22, 2023 | msn.comKadjebi GHS exceeds SMC registration, dosing targetNovember 13, 2023 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2023November 6, 2023 | msn.comGHS to launch “ART at 20 celebrations” to showcase impact on livesAugust 25, 2023 | markets.businessinsider.comMaxim Group Sticks to Their Buy Rating for Guardion Health Sciences (GHSI)August 14, 2023 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2023July 1, 2023 | finance.yahoo.comGHSI - Guardion Health Sciences, Inc.June 28, 2023 | finance.yahoo.comGuardion Health Sciences Insider Ups Holding By 115% During YearMay 30, 2023 | seekingalpha.comGuardion Health Sciences appoints president and CEOMay 30, 2023 | finance.yahoo.comGuardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive OfficerSee More Headlines Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/28/2024Today4/22/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:GHSI CUSIPN/A CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees9Year Founded2009Profitability EPS (Most Recent Fiscal Year)$0.11 Trailing P/E Ratio72.92 Forward P/E RatioN/A P/E GrowthN/ANet Income$160,000.00 Net Margins0.51% Pretax Margin1.29% Return on Equity2.01% Return on Assets1.21% Debt Debt-to-Equity RatioN/A Current Ratio9.01 Quick Ratio6.98 Sales & Book Value Annual Sales$12.25 million Price / Sales0.84 Cash Flow$0.14 per share Price / Cash Flow57.43 Book Value$6.39 per share Price / Book1.26Miscellaneous Outstanding Shares1,280,000Free Float1,267,000Market Cap$10.27 million OptionableNot Optionable Beta0.87 Social Links 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Robert Neal Weingarten (Age 72)Independent Chairman & Secretary Comp: $79kMr. Craig J. Sheehan (Age 53)Chief Commercial Officer Comp: $256.88kMs. Janet Hall (Age 65)President & CEO Ms. Katie Cox (Age 54)Chief Accounting Officer Key CompetitorsElevai LabsNASDAQ:ELABPurple BiotechNASDAQ:PPBTMoleculin BiotechNASDAQ:MBRXAlterity TherapeuticsNASDAQ:ATHEAeterna ZentarisNASDAQ:AEZSView All Competitors GHSI Stock Analysis - Frequently Asked Questions Should I buy or sell Guardion Health Sciences stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GHSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GHSI, but not buy additional shares or sell existing shares. View GHSI analyst ratings or view top-rated stocks. How have GHSI shares performed in 2024? Guardion Health Sciences' stock was trading at $5.34 at the beginning of the year. Since then, GHSI stock has increased by 50.2% and is now trading at $8.02. View the best growth stocks for 2024 here. Are investors shorting Guardion Health Sciences? Guardion Health Sciences saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 139,800 shares, an increase of 14.2% from the March 15th total of 122,400 shares. Based on an average trading volume of 208,600 shares, the days-to-cover ratio is presently 0.7 days. Currently, 13.7% of the shares of the company are sold short. View Guardion Health Sciences' Short Interest. When is Guardion Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our GHSI earnings forecast. How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) announced its quarterly earnings results on Thursday, March, 28th. The company reported $0.33 earnings per share (EPS) for the quarter. The firm earned $21.56 million during the quarter. Guardion Health Sciences had a net margin of 0.51% and a trailing twelve-month return on equity of 2.01%. When did Guardion Health Sciences' stock split? Guardion Health Sciences shares reverse split on the morning of Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL). When did Guardion Health Sciences IPO? Guardion Health Sciences (GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital served as the underwriters for the IPO. How do I buy shares of Guardion Health Sciences? Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:GHSI) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
